WO2007038861A1 - Procede et appareil permettant de predire la survenue potentielle d'evenements de fibrillation atriale - Google Patents

Procede et appareil permettant de predire la survenue potentielle d'evenements de fibrillation atriale Download PDF

Info

Publication number
WO2007038861A1
WO2007038861A1 PCT/CA2006/001622 CA2006001622W WO2007038861A1 WO 2007038861 A1 WO2007038861 A1 WO 2007038861A1 CA 2006001622 W CA2006001622 W CA 2006001622W WO 2007038861 A1 WO2007038861 A1 WO 2007038861A1
Authority
WO
WIPO (PCT)
Prior art keywords
heart
atrial fibrillation
occurrence
likelihood
data regarding
Prior art date
Application number
PCT/CA2006/001622
Other languages
English (en)
Inventor
Pierre Page
Alain Vinet
René CARDINAL
Original Assignee
Hopital Du Sacre-Coeur De Montreal
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Hopital Du Sacre-Coeur De Montreal filed Critical Hopital Du Sacre-Coeur De Montreal
Publication of WO2007038861A1 publication Critical patent/WO2007038861A1/fr

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61N—ELECTROTHERAPY; MAGNETOTHERAPY; RADIATION THERAPY; ULTRASOUND THERAPY
    • A61N1/00—Electrotherapy; Circuits therefor
    • A61N1/18—Applying electric currents by contact electrodes
    • A61N1/32—Applying electric currents by contact electrodes alternating or intermittent currents
    • A61N1/36—Applying electric currents by contact electrodes alternating or intermittent currents for stimulation
    • A61N1/362—Heart stimulators
    • A61N1/365—Heart stimulators controlled by a physiological parameter, e.g. heart potential
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B5/00—Measuring for diagnostic purposes; Identification of persons
    • A61B5/24—Detecting, measuring or recording bioelectric or biomagnetic signals of the body or parts thereof
    • A61B5/316—Modalities, i.e. specific diagnostic methods
    • A61B5/318—Heart-related electrical modalities, e.g. electrocardiography [ECG]
    • A61B5/346—Analysis of electrocardiograms
    • A61B5/349—Detecting specific parameters of the electrocardiograph cycle
    • A61B5/361—Detecting fibrillation
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B5/00—Measuring for diagnostic purposes; Identification of persons
    • A61B5/72—Signal processing specially adapted for physiological signals or for diagnostic purposes
    • A61B5/7235—Details of waveform analysis
    • A61B5/7239—Details of waveform analysis using differentiation including higher order derivatives

Definitions

  • the present invention relates to heart monitoring and treatment, and, more particularly, to a method and an apparatus for predicting potential occurrence of atrial fibrillation events.
  • Cardiac arrhythmia is a condition wherein a heart experiences an irregular and abnormal cardiac rhythm that differs from its normal sinus rhythm.
  • One type of cardiac arrhythmia is atrial fibrillation in which uncoordinated electrical impulses in a heart's atria cause the atria to fibrillate instead of contracting normally, thereby resulting in ineffective pumping of blood and an irregular and abnormal cardiac rhythm.
  • Atrial fibrillation is usually not in itself considered life-threatening. However, people with atrial fibrillation are at an increased risk for blood clots and strokes and, if left unattended to, the irregular and abnormal cardiac rhythm associated with atrial fibrillation can lead to heart attack and heart failure. Less severe symptoms of atrial fibrillation include weakness, shortness of breath, and heart palpitations.
  • cardioversion may be performed in an attempt to convert the irregular and abnormal cardiac rhythm to a normal sinus rhythm.
  • Cardioversion performed on the patient may include administration of medication, electrical stimulation, or a combination thereof.
  • a surgical intervention including implantation of a permanent pacemaker to regulate the cardiac rhythm combined with a drug therapy may be effected to treat atrial fibrillation.
  • Atrial fibrillation results from an underlying condition such as high blood pressure or other heart disease and progressively develops over time with atrial fibrillation episodes occurring more frequently and having a longer duration as time passes.
  • Atrial fibrillation may occur suddenly consequent to a certain event.
  • cardiac surgery performed on a patient
  • a drug therapy directed to preventing occurrence of atrial fibrillation is performed on the patient.
  • the patient may still experience one or more atrial fibrillation episodes of various lengths, usually beginning two or three days after surgery.
  • atrial fibrillation does occur, the patient's hospital stay after surgery is normally prolonged by two to five days due to a need for additional medication including antiarrhythmic and anticoagulation drugs.
  • Cardioversion is performed on the patient only if and when an atrial fibrillation episode is detected, which may take several minutes or hours.
  • the patient is normally required to continue to take medication directed to preventing occurrence of atrial fibrillation for a period of time typically between four to twelve weeks. Therefore, the patient (1) must experience a hospital stay that may be unnecessarily long to take into account potential occurrence of atrial fibrillation which may never occur; (2) can only be treated for atrial fibrillation following its detection; and (3) must take medication directed to preventing occurrence of atrial fibrillation for a relatively long period of time following surgery.
  • the invention provides a device comprising an input for receiving at least one signal indicative of activity of a heart and a processing unit coupled to the input.
  • the processing unit is operative for deriving data regarding a plurality of cardiac parameters of the heart based at least in part on the at least one signal.
  • the processing unit is further operative for determining a likelihood of occurrence of atrial fibrillation of the heart based at least in part on a correlation between the data regarding a first one of the cardiac parameters and the data regarding a second one of the cardiac parameters.
  • a device as defined above is implantable in a subject.
  • an implantable pacemaker comprises a device as defined above.
  • the invention provides a computer-readable medium tangibly embodying a program element executable by a computing device to cause the computing device to (1) derive data regarding a plurality of cardiac parameters of a heart based at least in part on at least one signal indicative of activity of the heart; and (2) determine a likelihood of occurrence of atrial fibrillation of the heart based at least in part on a correlation between the data regarding a first one of the cardiac parameters and the data regarding a second one of the cardiac parameters.
  • the invention provides a method for medical treatment.
  • the method comprises: receiving at least one signal from at least one electrode contacting a heart of a subject; determining a likelihood of occurrence of atrial fibrillation of the heart prior to manifestation of atrial fibrillation at least in part on a basis of information derived from the at least one signal; and - conditioning medical treatment of the subject at least in part on a basis of the likelihood of occurrence of atrial fibrillation of the heart.
  • the invention provides a method for recovery treatment of a subject that has undergone heart surgery.
  • the method comprises: receiving at least one signal from at least one electrode positioned in contact with a heart of the subject during the heart surgery; - determining a likelihood of occurrence of atrial fibrillation of the heart prior to manifestation of atrial fibrillation of the heart at least in part on a basis of information derived from the at least one signal; and conditioning recovery treatment of the subject at least in part on a basis of the likelihood of occurrence of atrial fibrillation of the heart.
  • the invention provides a method for recovery treatment of a subject that has undergone heart surgery.
  • the method comprises: receiving at least one signal from at least one electrode positioned in contact with a heart of the subject during the heart surgery; - determining a likelihood of occurrence of atrial fibrillation of the heart prior to manifestation of atrial fibrillation of the heart at least in part on a basis of information derived from the at least one signal; and conditioning a length of a hospital stay of the subject at least in part on a basis of the likelihood of occurrence of atrial fibrillation of the heart.
  • the invention provides a method for recovery treatment of a subject that has undergone heart surgery.
  • the method comprises: receiving at least one signal from at least one electrode positioned in contact with a heart of the subject during the heart surgery; - determining a likelihood of occurrence of atrial fibrillation of the heart prior to manifestation of atrial fibrillation of the heart at least in part on a basis of information derived from the at least one signal; selecting between a plurality of treatment options at least in part on a basis of the likelihood of occurrence of atrial fibrillation of the heart, the plurality of treatment options including: dispensing medication to the subject in an attempt to prevent occurrence of atrial fibrillation of the heart; precluding dispensing medication to the subject in an attempt to prevent occurrence of atrial fibrillation of the heart; implementing one of the treatment options on a basis of the selecting.
  • the invention provides a method for recovery treatment of a subject that has undergone heart surgery.
  • the method comprises: receiving at least one signal from at least one electrode positioned in contact with a heart of the subject during the heart surgery; determining a likelihood of occurrence of atrial fibrillation of the heart prior to manifestation of atrial fibrillation of the heart at least in part on a basis of information derived from the at least one signal; selecting between a plurality of treatment options at least in part on a basis of the likelihood of occurrence of atrial fibrillation of the heart, the plurality of treatment options including: - performing electrical stimulation of the heart of the subject in an attempt to prevent occurrence of atrial fibrillation of the heart; precluding performing electrical stimulation of the heart of the subject in an attempt to prevent occurrence of atrial fibrillation of the heart; implementing one of the treatment options on a basis of said selecting.
  • Figure 1 is a diagrammatic view of an apparatus for performing a prediction regarding atrial fibrillation of a heart of a patient, in accordance with a first specific embodiment of the present invention
  • Figure 2 is a flow chart illustrating operation of a processing unit of the apparatus shown in Figure 1 , in a particular example of implementation;
  • Figure 3 is a block diagram illustrating interaction of the processing unit of the apparatus shown in Figure 1 with a communication device, in a particular example of implementation;
  • Figure 4 is a block diagram illustrating interaction of the processing unit of the apparatus shown in Figure 1 with a treatment unit, in a particular example of implementation.
  • Figure 5 is a diagrammatic view of an implantable apparatus for performing a prediction regarding atrial fibrillation of a heart of a patient, in accordance with a second specific embodiment of the present invention.
  • Figure 1 shows an apparatus 10 for performing a prediction regarding atrial fibrillation of a heart 12 of a patient, in accordance with a first specific embodiment of the present invention.
  • the apparatus 10 is usable, for example, following cardiac surgery performed on the patient in order to predict whether the heart 12 may experience an atrial fibrillation episode.
  • the apparatus 10 comprises three electrodes 14i-14 3 contacting the heart 12 and a processing unit 22 coupled to the electrodes 14i-14 3 via an input 20.
  • the processing unit 22 interacts with the electrodes 14j-14 3 to monitor electrophysiological activity of the heart 12 and perform a prediction regarding potential occurrence of an atrial fibrillation event based at least in part on this monitored electrophysiological activity.
  • various prophylactic actions such as electrical stimulation of the heart 12, administration of antiarrythmic drugs, or both, may be performed in an attempt to prevent occurrence of an atrial fibrillation episode of the heart 12.
  • each of the electrodes 14pl4 3 contacts a respective portion of the heart 12 and is operative to sense electrophysiological activity of that portion of the heart 12 and transmit to the processing unit 22 a signal indicative of this electrophysiological activity.
  • the signal indicative of electrophysiological activity may be a signal indicative of an electric potential of the respective portion of the heart 12.
  • the electrode 14i contacts the heart 12 at a right atrium/sinoatrial node (RA/SA node) region thereof
  • the electrode 14 2 contacts the heart 12 at a low right atrium (low RA) region thereof
  • the electrode 14 3 contacts the heart 12 at a left atrium (LA) region thereof.
  • Each of the electrodes 14j-14 3 may be a commercially-available temporary epicardial electrode that is sutured or otherwise attached to the epicardium of the heart 12 by a surgeon at the end of the cardiac surgery performed on the patient.
  • Each of the electrodes 14 r 143 extends through the body of the patient and is coupled to the processing unit 22 via the input 20.
  • Electrodes 14i-14 3 Although in the embodiment shown in Figure 1 three electrodes 14i-14 3 are used, it is to be understood that one, two or any number of electrodes may be used without departing from the scope of the invention. Furthermore, while in the embodiment shown in Figure 1 a certain disposition of the electrodes 14]-14 3 is presented, it is to be understood that any disposition of the electrodes may be employed (e.g., one electrode in the SA node region and two electrodes in the LA region).
  • the processing unit 22 is operative to process signals received from the electrodes 14i-14 3 so as to perform a prediction regarding atrial fibrillation of the heart 12. More specifically, the processing unit 22 uses signals received from the electrodes 14i-14 3 to monitor how a plurality of parameters characterizing activity of the heart 12 correlate with each other and determines a likelihood of occurrence of an atrial fibrillation episode of the heart 12 based at least in part on this monitoring.
  • the processing unit 22 includes a Holter monitoring module coupled to the electrodes 14i- 14 3 for receiving signals therefrom and a computer coupled to the Holter monitoring module for processing the received signals.
  • the processing unit 22 may be implemented using hardware, firmware, software, control logic, or a combination thereof.
  • FIG. 2 illustrates operation of the processing unit 22 in a particular non-limiting example of implementation.
  • the period of time T may be two hours and each time interval At may be of two minutes for a number of time intervals N lnU , n ⁇ of 60.
  • Step 202 The processing unit 22 derives data regarding a number of normal sinus beats ( ⁇ SB) N NSB , and a number of premature atrial contractions (PAC) N PAC l in the time interval At 1 based at least in part on signals received from the electrodes 14]-14 3 . More particularly, the processing unit 22 detects each beat B k , in the time interval At 1 based on the magnitude of the signals received from the electrodes 14i-14 3 . The processing unit 22 also derives for each detected beat B k l data regarding a number of parameters characterizing that beat, based on the signals received from the electrodes 14j-14 3 .
  • ⁇ SB normal sinus beats
  • PAC premature atrial contractions
  • the processing unit 22 may derive values of the following time parameters characterizing each beat B k , based on activation times of the electrodes 14 r 14 3 : / itit ra-ult ial , c ami , Parameter indicative of an intra-atrial conduction time, which may J be the intra-atrial conduction time itself. Values of two such conduction times may be derived in the non-limiting example of implementation shown in Figure 1, namely: (1) the right atrial conduction time corresponding to the time interval between the activation time of the electrode and the activation time of the electrode 14 2 , and (2) the total atrial conduction time corresponding to the time interval between the activation time of the electrode 14i and the activation time of the electrode 14 3 .
  • t atrioventricul .ar cona Parameter indicative of an atrioventricular conduction time, which may J be the atrioventricular conduction time itself.
  • ventricular activity is captured and represented in signals received from the electrodes 14]-143.
  • a value of an atrioventricular conduction time, for example, for the right atrium/ventricle, may thus be derived on a basis of signals received from the electrodes 14i-14 3 by computing a time interval between signal components associated with atrial activity and signal components associated with ventricular activity.
  • dv Parameter indicative of a time derivative of the signal of one of the electrodes 14]- 14 3 which may be the time derivative itself. Values of three such time derivatives may be derived in the non-limiting example of implementation shown in Figure 1, namely: (1) the time derivative of the signal received from the electrode 14i; (2) the time derivative of the signal received from the electrode 14 2 ; and (3) the time derivative of the signal received from the electrode 14 3 .
  • Step 204 Based on the derived data regarding the parameters characterizing each beat B k , , the processing unit 22 determines whether each beat B k l is a NSB or a PAC so as to obtain the number of NSBs N NSB l and the number of PACs N FAC l in the time interval At 1 . Step 204:
  • the processing unit 22 derives data regarding a plurality of cardiac parameters X r ..X u based at least in part on signals received from the electrodes 14i-14 3 .
  • Each of the cardiac parameters X r ..X u is a parameter characterizing activity of the heart 12.
  • each of the cardiac parameters X v ..X ⁇ U may be a
  • a given one of the cardiac parameters X r ..X Xf may also be a parameter indicative of a time integral of the signal of one of the electrodes 14i-14j during each NSB NSB 1 , .
  • an intra-atrial conduction time which may be the intra- atrial conduction time itself.
  • Values of two such conduction times may be derived in the non-limiting example of implementation shown in Figure 1, namely: (1) the right atrial conduction time corresponding to the time interval between the activation time of the electrode 14i and the activation time of the electrode 14 2 , and (2) the total atrial conduction time corresponding to the time interval between the activation time of the electrode 14] and the activation time of the electrode ⁇ 4 ⁇ .
  • ventricular activity is captured and represented in signals received from the electrodes 14 1 - 14 3 .
  • a value of an atrioventricular conduction time may thus be derived on a basis of signals received from the electrodes 14[-H 3 by computing a time interval between signal components associated with atrial activity and signal components associated with ventricular activity.
  • dv Parameter indicative of a time derivative of the signal from one of the
  • r electrodes 14 r 14 3 which may be the time derivative itself. Values of three such time derivatives may be derived in the non-limiting example of implementation shown in Figure 1, namely: (1) the time derivative of the signal received from the electrode 14i; (2) the time derivative of the signal received from the electrode 14 2 ; and (3) the time derivative of the signal received from the electrode 14 3 .
  • f v fa Parameter indicative of a time integral of the signal of one of the electrodes 14i-14 3 which may be the time integral itself. Values of three such time integrals may be derived in the non-limiting example of implementation shown in Figure 1, namely: (1) a time integral of the signal of the electrode 14j; (2) a time integral of the signal of the electrode 14 2 ; and (3) a time integral of the signal of the electrode 14 3 .
  • Parameter indicative of heart period based on atrial activation which may be the heart period itself.
  • a value of this parameter may be derived, for example, on a basis of the signal received from the electrode 14] by computing a time interval between successive activation of the right atrium.
  • X, is the time derivative of the signal received from the electrode 14 2 ; dt
  • X s Jv dt is the time integral of the signal received from the electrode H 2 ;
  • X 9 Jv dt is the time integral of the signal received from the electrode H 3 ;
  • the processing unit 22 derives a series of data elements (x, ,...,x v ), discipline , such as values for each cardiac parameter X 1n , where m e (L..., M) .
  • Step 206
  • the processing unit 22 For each pair of cardiac parameters (X p ;X q ) , where (p,q) e (l,...,M)and p ⁇ q , the processing unit 22 derives an indication of a level of correlation C(X p ',X 11 ), between the data regarding the cardiac parameter X p and the data regarding the cardiac parameter X q . More particularly, the processing unit 22 derives an indication of a level of correlation C(X p ; X 11 ), between the series of data elements (x, ,...,x ⁇ ) p ⁇ for the cardiac parameter X p and the series of data elements (x, ,...,x V ⁇ ) q ⁇ for the cardiac parameter X q .
  • the indication of the level of correlation C(X p ⁇ X q ) may be the coefficient of correlation or covariance between the series of data elements (x, ,...,x ⁇ ) /; , and the series of data elements (x, ,...,x N ) (/ , , or any other conceivable indication of the level of correlation between these two series of data elements.
  • the indication of the level of correlation may be the correlation coefficient expressed as:
  • x p is the mean of the series of data elements (x, ,...,x ⁇ ) p l and x q is the mean of the series of data elements (x, ,...,x N SB ) q , .
  • the processing unit 22 obtains a set of correlation indicators
  • each pair of cardiac parameters (X p ; X q ) formable from the M cardiac parameters produces the set of R correlation indicators
  • only a subset of these pairs (i.e., not all of these pairs) may be taken into consideration, thereby producing a set of correlation indicators containing less than R correlation indicators.
  • Step 208
  • the index i is equal to N int em//s .
  • the last considered time interval At 1 was the last time interval in the period of time T and step 210 is performed; otherwise, the value of the index i is incremented by one and the processing unit 22 returns to step 202.
  • Step 210
  • the processing unit 22 For each indication of a level of correlation C 1 . , where r e ( ⁇ ,...,R) , the processing unit 22 derives an indication of a probability of stability over time of that indication C 1 . , P(C 1 . ) . More specifically, the processing unit 22 derives the indication of the probability of stability over time P(C 1 .) based on the values of C 1 . ,...., C 1 . ⁇ .
  • the processing unit 22 derives an indication of a probability of stability over time of the indication of the level of correlation C 1 , f(C, ) , based on the values of C i ,,...,C 1 v ; an indication of a probability of stability over time of the indication of the level of correlation C 2 , P(C 2 ) , based on the values of C 2 1 ,..., C 2 N ; and so on.
  • the value of each P(C r ) is obtained by applying a non-parametric statistical method on the values of C r ] ,...,C r X a ⁇ .
  • the non- parametric statistical method which is based on the technique of surrogate data, computes a weighted sum of the values of C,. ,,..., C,. V ( ( using a set of weights reflecting a temporal ordering of the values of C 1 . ,,..., C 1 . ⁇ , for instance, the index / of the time intervals.
  • Surrogate time series are generated by random permutations of the values of C 1 . ,,...,C,. ⁇ ⁇ and, for each generated surrogate time series, a respective weighted sum of the randomly permutated values of C r ] ,...,C r N is computed, thereby resulting in a distribution of the weighted sum under consideration.
  • the value of each P(C 1 .) is obtained by comparing the actual weighted sum of the values of C 1 . ,,..., C 1 . v to the distribution of the weighted sums for the surrogate time series.
  • This probability of stability vector P is indicative of the degree of temporal stability of the respective level of correlation between each pair of cardiac parameters
  • a given entry P(C 1 . ) in the probability of stability vector P is indicative of how stable the level of correlation C 1 . between the pair of cardiac parameters (X p ;X q ) ⁇ s over time.
  • Step 212
  • the processing unit 22 determines a likelihood of occurrence of atrial fibrillation of the heart
  • the processing unit 12 based at least in part on the respective level of correlation between each pair of cardiac parameters (X p ; X 11 ) . More specifically, in this particular embodiment, the processing unit
  • determining a likelihood of occurrence of atrial fibrillation of the heart 12 comprises deriving a quantitative indication of a likelihood of occurrence of atrial fibrillation of the heart 12, based at least in part on the data regarding the levels of correlation.
  • this quantitative indication may be a probability of occurrence of atrial fibrillation of the heart 12 or any other indicator quantifying the risk that atrial fibrillation of the heart 12 may occur.
  • the quantitative indication of a likelihood of occurrence of atrial fibrillation of the heart 12 is the result of a function of the probabilities of stability /(P(C, ),..., P(C R )) .
  • determining a likelihood of occurrence of atrial fibrillation of the heart 12 comprises determining whether a condition related to atrial fibrillation of the heart 12 is satisfied, based at least in part on the data regarding the levels of correlation. When the condition is determined to be satisfied, an atrial fibrillation episode of the heart 12 is deemed likely to occur. When the condition is determined to be not satisfied, an atrial fibrillation episode of the heart 12 is deemed unlikely to occur.
  • Satisfaction of the condition related to atrial fibrillation of the heart 12 may take on various forms depending on how this condition is defined. For example, the condition may be deemed to be satisfied if the value of each probability of stability P(C 1 ) is less than a respective predetermined threshold P 1 (C 1 ) , i.e. P(C 1 ) ⁇ P 1 (C 1 ) , P(C 2 ) ⁇ P 1 (C 2 ) , and so on.
  • condition may be deemed to be satisfied if the result ; ⁇ of a function of the probabilities of stability g(P(C ⁇ ),..., P(C R )) is greater than a predetermined threshold y t (or less than the predetermined threshold y, , depending on how the function is defined).
  • the function g(P(C x ),...,P(C R )) may be the function /(P(C 1 ),..., P(C n )) mentioned above which is used to derive a quantitative indication of a likelihood of occurrence of atrial fibrillation of the heart 12, in which case the result y is the quantitative indication of a likelihood of occurrence of atrial fibrillation (e.g., a probability of occurrence of atrial fibrillation of the heart 12).
  • the condition may be defined in various other ways without departing from the scope of the invention. For instance, the condition may be defined such that it is deemed to be satisfied when each of a plurality of sub- conditions is satisfied.
  • the processing unit 22 determines this likelihood also based at least in part on data regarding at least one cardiac parameter Z .
  • the data regarding each cardiac parameter Z may be derived, for instance, at step 202 or step 204.
  • the cardiac parameter Z is a function of the number of PACs N PAi , in each time interval
  • N PAi , ⁇ T N PAC , , or the density of PACs for the period of time T , N P4i , IT . hi such a case
  • determining a likelihood of occurrence of atrial fibrillation comprises determining whether a condition is satisfied
  • the condition may be deemed to be satisfied, for example, if the value of each probability of stability P(C 1 ) is less than a respective predetermined threshold P 1 (C, ) (or if the result y of a function of the probabilities of stability g(P(C ] ),..., P(C R )) is greater (or less) than a predetermined threshold y, ), and the total number of P ACs N P4( , is greater than a certain value.
  • the processing unit 22 has determined a likelihood of occurrence of atrial fibrillation of the heart 12.
  • Atrial fibrillation occurred at 2.8 ⁇ 1.2 days postoperatively in fifteen patients referred to as Group I patients (mean age of 67 years old). Measurements in Group I patients data sets were made on a beat-to-beat basis over two-hour intervals preceding atrial fibrillation episodes and compared to randomly selected two-hour intervals in fifteen patients without postoperative atrial fibrillation, referred to as Group II patients (mean age of 63 years old). The parameters were grouped in pairs to assess their correlation throughout the study intervals, thereby forming a set of 27 variables. The temporal stability of each correlation variable, expressed as a probability, was tested using a non-parametric method with reference to time series consisting of random permutations.
  • the processing unit 22 upon completing step 212, has determined a likelihood of occurrence of atrial fibrillation of the heart 12. Based on this determined likelihood, the processing unit 22 may perform various actions, examples of which will now be described with reference to Figures 3 and 4.
  • Figure 3 illustrates a first example of an action that may be performed by the processing unit 22 based on the determined likelihood of occurrence of atrial fibrillation of the heart 12.
  • the processing unit 22 is operative to generate a signal that is released via an output 30 to a notification device 32 so as to cause the notification device 32 to provide an indication of the likelihood of occurrence of atrial fibrillation of the heart 12.
  • the notification device 32 may be a bedside computer terminal adjacent to the patient and the indication of the likelihood of occurrence of atrial fibrillation of the heart 12 may be provided by displaying information on a display of the bedside computer terminal.
  • the processing unit 22 determines a quantitative indication of a likelihood of occurrence of atrial fibrillation of the heart 12
  • the displayed information can include this quantitative indication itself, e.g.. a probability of occurrence of an atrial fibrillation episode of the heart 12.
  • the displayed information may include a message characterizing a risk that atrial fibrillation may occur such as "High risk of atrial fibrillation” if the condition is satisfied or "Low risk of atrial fibrillation” if the condition is not satisfied.
  • the processing unit 22 may generate and transmit a signal to the notification device 32 only responsive to a determination that the condition is satisfied. In such a case, the signal sent to the notification device 32 acts as an alarm signal to indicate likely occurrence of an atrial fibrillation episode of the heart 12.
  • the notification device 32 is a bedside computer terminal, it is to be understood that the notification device 32 can take on various forms.
  • the notification device 32 can be a static notification device such as a computer terminal or a mobile notification device (including a mobile communication device) such as a laptop computer, a tablet personal computer (PC), a portable digital assistant (PDA), a wide local area network (WLAN) phone, a cellular phone, or any other conceivable device capable of providing a perceivable indication of the likelihood of occurrence of atrial fibrillation of the heart.
  • the signal generated by the processing unit 22 may be transmitted to the notification device 32 via a wired link, a wireless link, or a combination thereof, depending on whether the notification device 32 is static or mobile.
  • visual means are used to indicate potential occurrence of an atrial fibrillation episode, it will be appreciated that audible alarm signals may also be used to indicate potential occurrence of an atrial fibrillation episode.
  • the notification device 32 providing an indication of a likelihood of occurrence of atrial fibrillation of the heart 12 enables medical personnel responsible for the patient to provide adequate treatment to the patient so as to attempt to prevent an atrial fibrillation episode of the heart 12.
  • the medical personnel may give prophylactic treatment to the patient in an attempt to prevent occurrence of an atrial fibrillation episode.
  • the prophylactic treatment may include electrical stimulation (e.g. rapid atrial pacing) of the heart 12 using, for example, an electrical cardioversion unit or temporary pacemaker which may be available in proximity of the patient.
  • the electrical stimulation may be a so-called "overdrive” pacing of the heart 12, which imposes a pacing faster than the normal sinus rhythm of the heart 12 but slower than an atrial fibrillation rhythm.
  • the prophylactic treatment may include administration of antiarrhythmic drugs such as ibutilide, procainamide, flecainide, propafenone, sotalol, amidodarone, or any other drug useful in preventing or treating arrhythmia.
  • the prophylactic treatment may include a combination of both electrical stimulation of the heart 12 and administration of drugs to the patient.
  • giving prophylactic treatment to the patient based on the determined likelihood of occurrence of atrial fibrillation may prevent an actual atrial fibrillation episode of the heart 12 from occurring.
  • this reduces the risk of negative effects associated with atrial fibrillation such as uncomfortable symptoms of and complications resulting from atrial fibrillation, irregular cardiac rhythm, strokes, necessity for anticoagulation drugs, prolongation of hospital stay, etc.
  • information regarding the determined likelihood of occurrence of atrial fibrillation of the heart 12 may be relied on to preclude administration of certain types of treatment to the patient (e.g., preclude administration of certain medication or preclude electrical stimulation treatments). This may avoid provision of unnecessary treatment in some cases.
  • information regarding the determined likelihood of occurrence of atrial fibrillation of the heart 12 may also be used for adjusting a length of the hospital stay of the patient. For instance, the length of the hospital stay of the patient when this determined likelihood indicates that atrial fibrillation of the heart 12 is unlikely to occur may be less than when this determined likelihood indicates that atrial fibrillation is likely to occur. This can avoid patients experiencing unnecessary prolonged hospital stays when the risk of occurrence of atrial fibrillation is relatively low.
  • the processing unit 22 is operative to generate a signal that is released via an output 34 to a treatment unit 40 proximate to the patient so as to cause the treatment unit 40 to provide treatment to the patient directed to preventing an atrial fibrillation episode of the heart 12.
  • the treatment unit 40 may be implemented as a bedside treatment unit or a unit worn by the patient.
  • the treatment unit 40 is adapted to automatically provide treatment to the patient directed to preventing an atrial fibrillation episode of the heart 12 in response to receiving a signal from the processing unit 22.
  • the treatment unit 40 is capable of operating in a plurality of operative conditions and, responsive to receiving a signal from the processing unit 22, the treatment unit 40 is caused to acquire one of these operative conditions.
  • the treatment unit 40 may include an electrical stimulation unit for electrically stimulating the heart 12.
  • the electrical stimulation unit may comprise a pulse generator adapted to generate electric pulses for electrically stimulating the heart 12, the pulses being transmitted to the heart 12 via one or more of the electrodes 14i-14 3 or via another electrode (not shown) such as a permanently implanted heart lead.
  • the treatment unit 40 may include a drug administration unit for automatically administrating drugs to the patient.
  • the drug administration unit may comprise a container containing one or more pharmacological agents, a controllable pump connected to the container, and a conduit linking the pump to the patient's bloodstream so as to controllably release the pharmacological agents in the patient's bloodstream.
  • the treatment unit 40 may include both an electrical stimulation unit and a drug administration unit for automatically electrically stimulating the heart 12 and administrating medication to the patient.
  • the processing unit 22 may generate a signal that is sent to the treatment unit 40. For instance, in an embodiment in which atrial fibrillation of the heart 12 is deemed likely or unlikely to occur based on whether a condition is or is not satisfied, the processing unit 22 may generate a signal that is transmitted to the treatment unit 40 in response to a determination that the condition is satisfied. Responsive to receiving the signal from the processing unit 22, the treatment unit 40 acquires an operative condition in which it automatically provides treatment to the patient directed to preventing an atrial fibrillation episode of the heart 12.
  • the treatment unit 40 in response to receiving the signal from the processing unit 22, the electrical stimulation unit provides an electrical stimulation treatment of the heart 12 in an attempt to prevent atrial fibrillation of the heart 12.
  • the electrical stimulation treatment may be in the form of an overdrive pacing treatment.
  • the treatment unit 40 in response to receiving the signal from the processing unit 22, the drug administration unit administers drugs to the patient in an attempt to prevent atrial fibrillation of the heart 12.
  • the administered drugs may be any of the drugs previously mentioned.
  • the characteristics of the treatment provided to the patient may depend on the determined likelihood of occurrence of atrial fibrillation of the heart 12. For instance, in an embodiment in which the processing unit 22 determines a probability of occurrence of an atrial fibrillation episode of the heart 12, the characteristics of the treatment may be related to this probability. For example, a first probability of occurrence of an atrial fibrillation episode may result in a treatment having a first set of characteristics while a second, different probability of occurrence of an atrial fibrillation episode may result in a treatment having a second, different set of characteristics.
  • the characteristics of the treatment may be specified in terms of, e.g., electrical stimulation parameters (e.g. voltage, frequency, etc.) and/or medication administration parameters (e.g. type of medication, dosage, etc.).
  • electrical stimulation parameters e.g. voltage, frequency, etc.
  • medication administration parameters e.g. type of medication, dosage, etc.
  • Figure 5 shows an implantable apparatus 110 for performing a prediction regarding atrial fibrillation of a heart 112 of a patient, in accordance with a second non-limiting embodiment of the present invention.
  • the apparatus 110 is operative to predict whether the heart 112 may experience an atrial fibrillation episode.
  • the implantable apparatus 110 comprises three electrodes 114]- 114 3 contacting the heart 112 and an enclosure 120 within which is disposed a processing unit 122 coupled to the electrodes 114i-l 14 3 , a treatment unit 140 coupled to the processing unit 122, and a signaling unit 142 coupled to the processing unit 122.
  • a power source 134 such as a battery is also disposed within the enclosure 120 for powering the processing unit 122, the treatment unit 140, and the signaling unit 142.
  • the enclosure 120 is adapted to be implanted, for example, in an upper left chest portion of the patient within a subcutaneous pocket and may be made of a biocompatible material such as those conventionally used in manufacturing permanent pacemakers.
  • the processing unit 122 interacts with the electrodes 1 14i-l 14 3 to monitor electrophysiological activity of the heart 112 and determine a likelihood of occurrence of atrial fibrillation of the heart 112 based at least in part on this monitored electrophysiological activity. As also described below, based on the determined likelihood, the processing unit 122 may interact with the treatment unit 140 and the signaling unit 142 so as to cause electrical stimulation of the heart 112. administration of antiarrythmic drugs, or both, in order to attempt to prevent an atrial fibrillation episode of the heart 1 12.
  • each of the electrodes 1 14i-l 14 3 is operative to sense electrophysiological activity of a respective portion of the heart 112 and to transmit to the processing unit 122 a signal indicative of this sensed electrophysiological activity.
  • the signal indicative of electrophysiological activity may be a signal indicative of an electric potential of the respective portion of the heart 1 12.
  • the electrode 114i is disposed in a right atrium/sinoatrial node (RA/SA) region of the heart 112
  • the electrode 1 14 2 is disposed in a low right atrium (low RA) region of the heart 112
  • the electrode 114 3 is disposed in a left atrium (LA) region of the heart 112.
  • Each of the electrodes 114i-l 14 3 may be a commercially available electrode that is transvenously implanted into the heart 1 12 and fixed to the myocardium thereof by known means.
  • Electrodes 1 14i-l H 3 Although in the embodiment shown in Figure 5 three electrodes 1 14i-l H 3 are used, it is to be understood that one, two or any number of electrodes may be used without departing from the scope of the invention. Furthermore, while in the embodiment shown in Figure 5 a certain disposition of the electrodes 114 r l 14 3 is presented, it is to be understood that any disposition of the electrodes may be employed (e.g., one electrode in the SA node region and two electrodes in the LA region).
  • the processing unit 122 is coupled to the electrodes 114i-l 14 3 for receiving the signal from each of the electrodes 114(-114 3 .
  • the processing unit 122 operates as the processing unit 22 described previously in connection with Figures 1 and 2.
  • the processing unit 122 is operative to process signals received from the electrodes 114i-l 14 3 so as to determine a likelihood of occurrence of atrial fibrillation of the heart 112. Based on this determined likelihood, the processing unit 122 may perform various actions, examples of which will now be described.
  • the treatment unit 140 is adapted to automatically provide treatment to the patient directed to preventing an atrial fibrillation episode of the heart 1 12.
  • the treatment unit 140 may include an electrical stimulation unit for electrically stimulating the heart 112.
  • the electrical stimulation unit may comprise a pulse generator adapted to generate electric pulses for electrically stimulating the heart 1 12, the pulses being transmitted to the heart 1 12 via one or more of the electrodes 114i-l 14 3 or via another electrode (not shown) disposed within the heart 1 12.
  • the treatment unit 140 may include a drug administration unit for automatically administrating drugs to the patient.
  • the drug administration unit may comprise a container containing one or more pharmacological agents, a controllable pump connected to the container, and a conduit linking the pump to the patient's bloodstream so as to controllably release the pharmacological agents in the patient's bloodstream.
  • the treatment unit 140 may include both an electrical stimulation unit and a drug administration unit for automatically electrically stimulating the heart 112 and administrating medication to the patient.
  • the processing unit 122 may generate a signal that is sent to the treatment unit 140. For instance, in an embodiment in which atrial fibrillation of the heart 112 is deemed likely or unlikely to occur based on whether a condition is or is not satisfied, the processing unit 122 may generate a signal that is sent to the treatment unit 140 in response to a determination that the condition is satisfied. Responsive to receiving the signal from the processing unit 122, the treatment unit 140 automatically provides treatment to the patient directed to preventing an atrial fibrillation episode of the heart 112.
  • the electrical stimulation unit 140 in response to receiving the signal from the processing unit 122, provides an electrical stimulation treatment of the heart 112 in an attempt to prevent atrial fibrillation of the heart 112.
  • the electrical stimulation treatment may be in the form of an overdrive pacing treatment.
  • the drug administration unit in response to receiving the signal from the processing unit 122, administers drugs to the patient in an attempt to prevent atrial fibrillation of the heart 112.
  • the administered drugs may be any of the drugs previously mentioned.
  • the characteristics of the treatment provided to the patient may depend on the determined likelihood of occurrence of atrial fibrillation of the heart 112. For instance, in an embodiment in which the processing unit 122 determines a probability of occurrence of an atrial fibrillation episode of the heart 112, the characteristics of the treatment may be related to this probability. For example, a first probability of occurrence of an atrial fibrillation episode may result in a treatment having a first set of characteristics while a second, different probability of occurrence of an atrial fibrillation episode may result in a treatment having a second, different set of characteristics.
  • the characteristics of the treatment may be specified in terms of, e.g., electrical stimulation parameters (e.g. voltage, frequency, etc.) and/or medication administration parameters (e.g.
  • the processing unit 122 continuously monitors activity of the heart 1 12 and updates the assessment of the likelihood of occurrence of atrial fibrillation of the heart 112, the treatment provided to the patient is automatically regulated to ensure that the patient is provided with the optimal treatment at any given time.
  • the signaling unit 142 is adapted to provide a perceivable indication of the determined likelihood of occurrence of atrial fibrillation of the heart 112. More particularly, based on the determined likelihood of occurrence of atrial fibrillation of the heart 112, the processing unit 122 may generate a signal that is sent to the signaling unit 142. For instance, in an embodiment in which atrial fibrillation of the heart 112 is deemed likely or unlikely to occur based on whether a condition is or is not satisfied, the processing unit 122 may generate a signal that is sent to the signaling unit 142 in response to a determination that the condition is satisfied. Responsive to receiving the signal from the processing unit 122, the signaling unit 142 provides a perceivable indication that an atrial fibrillation episode of the heart 112 is likely to occur.
  • the signaling unit 142 may include an emitter adapted to emit an audible signal indicating that an atrial fibrillation episode of the heart 112 is likely to occur. Since in the embodiment shown in Figure 5, the signaling unit 142 is disposed within the enclosure 120 which is implanted in the patient, the emitted audible signal is sufficiently loud to be heard by the patient or any individual proximate to the patient. In other embodiments, the signaling unit 142 may be external to the patient. For instance, the signaling unit 142 may be implemented as a unit worn by the patient (e.g. a bracelet or wrist watch) or as a static or mobile notification device (including a mobile communication device).
  • the processing unit 122 may be operative to wirelessly send a signal to the signaling unit 142 using, for example, radio frequency (RF) technology.
  • RF radio frequency
  • the signaling unit 142 may include a display or other visual indicator for providing a visual indication regarding the likelihood of occurrence of an atrial fibrillation episode.
  • the perceivable indication of likely occurrence of atrial fibrillation of the heart 112 enables the patient or any individual perceiving the indication to become aware of the risk of atrial fibrillation and to take precautionary actions.
  • the patient may alter his or her ongoing activities (e.g. stop driving or stop exercising) until the indication of likely occurrence of atrial fibrillation of the heart 1 12 is no longer present.
  • the patient may proceed to take prescribed drugs in an attempt to prevent occurrence of atrial fibrillation.
  • the prescribed drugs may be any of the drugs previously mentioned.
  • the signaling unit 142 prompting the patient to take the necessary drugs is such that a drug administration unit may be omitted from the treatment unit 140.
  • the implantable apparatus 1 10 may comprise the signaling unit 142 and not include the treatment unit 140, in which case treatment provided to the patient is based solely on detection of the signal provided by the signaling unit 142.
  • processing unit 22 or 122 may be implemented as pre-programmed hardware or firmware elements (e.g., application specific integrated circuits (ASICs), electrically erasable programmable read-only memories (EEPROMs), etc.), or other related components.
  • the processing unit 22 or 122 may comprise an arithmetic and logic unit (ALU) having access to a code memory (not shown) which stores program instructions for the operation of the ALU in order to implement the functionality and execute the various processes and functions described above.
  • ALU arithmetic and logic unit
  • the program instructions may be stored on a medium which is fixed, tangible and readable directly by the processing unit 22 or 122, (e.g., removable diskette, CD-ROM, ROM, or fixed disk), or the program instructions may be stored remotely but transmittable to the processing unit 22 or 122 via a modem or other interface device (e.g., a communications adapter) connected to a network over a transmission medium.
  • the transmission medium may be either a tangible medium (e.g.. optical or analog communications lines) or a medium implemented using wireless techniques (e.g., microwave, infrared or other transmission schemes).

Landscapes

  • Health & Medical Sciences (AREA)
  • Cardiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Biophysics (AREA)
  • Engineering & Computer Science (AREA)
  • Biomedical Technology (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Pathology (AREA)
  • Surgery (AREA)
  • Molecular Biology (AREA)
  • Medical Informatics (AREA)
  • Physics & Mathematics (AREA)
  • Physiology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Radiology & Medical Imaging (AREA)
  • Electrotherapy Devices (AREA)
  • Measurement And Recording Of Electrical Phenomena And Electrical Characteristics Of The Living Body (AREA)

Abstract

L'invention porte sur un dispositif comprenant une entrée destinée à recevoir au moins un signal indiquant l'activité d'un coeur, et une unité de traitement couplée à l'entrée. L'unité de traitement permet de dériver des données concernant une pluralité de paramètres cardiaques du coeur, fondées au moins en partie sur le signal précité. L'unité de traitement permet en outre de déterminer la probabilité de survenue d'une fibrillation atriale du coeur, fondée au moins en partie sur une corrélation entre les données concernant un premier paramètre parmi les paramètres cardiaques et les données concernant un second paramètre parmi les paramètres cardiaques. Dans un mode de réalisation exemplaire non limitatif, un dispositif tel que le dispositif précité est implanté chez un sujet. Par exemple, dans un exemple non limitatif de l'invention, un stimulateur cardiaque implantable comprend un dispositif tel que le dispositif précité. L'invention se rapporte également à un procédé de traitement médical et à un procédé de traitement de récupération d'un sujet ayant subi une opération de chirurgie cardiaque.
PCT/CA2006/001622 2005-10-04 2006-10-02 Procede et appareil permettant de predire la survenue potentielle d'evenements de fibrillation atriale WO2007038861A1 (fr)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US72297605P 2005-10-04 2005-10-04
US60/722,976 2005-10-04

Publications (1)

Publication Number Publication Date
WO2007038861A1 true WO2007038861A1 (fr) 2007-04-12

Family

ID=37905935

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/CA2006/001622 WO2007038861A1 (fr) 2005-10-04 2006-10-02 Procede et appareil permettant de predire la survenue potentielle d'evenements de fibrillation atriale

Country Status (1)

Country Link
WO (1) WO2007038861A1 (fr)

Cited By (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP2237836A1 (fr) * 2008-01-28 2010-10-13 St. Jude Medical AB Dispositif médical pour pronostiquer une fibrillation atriale
CN102058407A (zh) * 2011-02-09 2011-05-18 复旦大学 心室纤颤预测方法与装置
US8521277B2 (en) 2008-09-04 2013-08-27 Pacesetter, Inc. Implantable systems and method for use therewith for tracking changes in hemodynamics and cardiac disease

Citations (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5609158A (en) * 1995-05-01 1997-03-11 Arrhythmia Research Technology, Inc. Apparatus and method for predicting cardiac arrhythmia by detection of micropotentials and analysis of all ECG segments and intervals
US5954665A (en) * 1995-06-07 1999-09-21 Biosense, Inc. Cardiac ablation catheter using correlation measure
US6041251A (en) * 1998-07-01 2000-03-21 Cardiac Pacemakers, Inc. System and method for detecting atrial events of a heart
US6466819B1 (en) * 1999-06-25 2002-10-15 Biotronik Mess-Und Therapiegerate Gmbh & Co. Ingenieurburo Berlin Cardioelectric apparatus
US6490479B2 (en) * 2000-12-28 2002-12-03 Ge Medical Systems Information Technologies, Inc. Atrial fibrillation detection method and apparatus
US6760620B2 (en) * 2000-03-15 2004-07-06 Resolution Medical, Inc. Non-invasive localization and treatment of focal atrial fibrillation
US8162991B2 (en) * 2006-07-27 2012-04-24 K2M, Inc. Multi-planar, taper lock screw

Patent Citations (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5609158A (en) * 1995-05-01 1997-03-11 Arrhythmia Research Technology, Inc. Apparatus and method for predicting cardiac arrhythmia by detection of micropotentials and analysis of all ECG segments and intervals
US5954665A (en) * 1995-06-07 1999-09-21 Biosense, Inc. Cardiac ablation catheter using correlation measure
US6041251A (en) * 1998-07-01 2000-03-21 Cardiac Pacemakers, Inc. System and method for detecting atrial events of a heart
US6466819B1 (en) * 1999-06-25 2002-10-15 Biotronik Mess-Und Therapiegerate Gmbh & Co. Ingenieurburo Berlin Cardioelectric apparatus
US6760620B2 (en) * 2000-03-15 2004-07-06 Resolution Medical, Inc. Non-invasive localization and treatment of focal atrial fibrillation
US6490479B2 (en) * 2000-12-28 2002-12-03 Ge Medical Systems Information Technologies, Inc. Atrial fibrillation detection method and apparatus
US8162991B2 (en) * 2006-07-27 2012-04-24 K2M, Inc. Multi-planar, taper lock screw

Cited By (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP2237836A1 (fr) * 2008-01-28 2010-10-13 St. Jude Medical AB Dispositif médical pour pronostiquer une fibrillation atriale
EP2237836A4 (fr) * 2008-01-28 2011-06-01 St Jude Medical Dispositif médical pour pronostiquer une fibrillation atriale
US9026207B2 (en) 2008-01-28 2015-05-05 St Jude Medical Ab Medical device for Atrial fibrillation prediction
US8521277B2 (en) 2008-09-04 2013-08-27 Pacesetter, Inc. Implantable systems and method for use therewith for tracking changes in hemodynamics and cardiac disease
CN102058407A (zh) * 2011-02-09 2011-05-18 复旦大学 心室纤颤预测方法与装置
CN102058407B (zh) * 2011-02-09 2014-03-05 复旦大学 心室纤颤预测方法与装置

Similar Documents

Publication Publication Date Title
US11723537B2 (en) Heart failure monitoring
US10702213B2 (en) Differentiation of heart failure risk scores for heart failure monitoring
US10945614B2 (en) Systems and methods to determine HR, RR and classify cardiac rhythms based on atrial IEGM and atrial pressure signals
US20210204885A1 (en) Differentiation of heart failure risk scores for heart failure monitoring
US11202599B2 (en) Systems and methods for detecting arrhythmias
US7991460B2 (en) Methods and apparatus for detecting cardiac events based on heart rate sensitive parameters
CN105324076B (zh) 阶段式心律检测系统和方法
US11744478B2 (en) Absolute intrathoracic impedance based scheme to stratify patients for risk of a heart failure event
US20120109243A1 (en) Heart failure monitoring and notification
US20100168597A1 (en) Zoneless tachyarrhythmia detection with real-time rhythm monitoring
US20170245794A1 (en) Medical system for seamless therapy adjustment
CN113164065A (zh) 用于解决错误确定的心力衰竭监测算法的修改
WO2007038861A1 (fr) Procede et appareil permettant de predire la survenue potentielle d'evenements de fibrillation atriale
US11298068B2 (en) Systems and methods for detecting arrhythmias
CN111565634B (zh) 对缓慢且持续性心脏节律的检测
WO2023107330A1 (fr) Système de détection d'arythmies

Legal Events

Date Code Title Description
121 Ep: the epo has been informed by wipo that ep was designated in this application
NENP Non-entry into the national phase

Ref country code: DE

122 Ep: pct application non-entry in european phase

Ref document number: 06790783

Country of ref document: EP

Kind code of ref document: A1